Skip Navigation

Nephrology Dialysis Transplantation 2008 23(6):1792-1793; doi:10.1093/ndt/gfn249
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tonelli, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tonelli, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org


Reply

Marcello Tonelli

Division of Critical Care, University of Alberta, Edmonton, Canada

The first 10% of the full text of this article appears below.

Sir,

With respect, I believe that Drs Olgaard and Lewin have missed the point of Palmer's paper and the accompanying Editorial. Current use of activated vitamin D in contemporary haemodialysis patients is not restricted to dramatic examples of clinically evident deficiency like the child presented in their figure. Rather, a substantial proportion . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CJASNHome page
T. B. Drueke and E. Ritz
Treatment of Secondary Hyperparathyroidism in CKD Patients with Cinacalcet and/or Vitamin D Derivatives
Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 234 - 241.
[Abstract] [Full Text] [PDF]